BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17178919)

  • 1. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
    McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
    J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of core DNA elements that target somatic hypermutation.
    Kohler KM; McDonald JJ; Duke JL; Arakawa H; Tan S; Kleinstein SH; Buerstedde JM; Schatz DG
    J Immunol; 2012 Dec; 189(11):5314-26. PubMed ID: 23087403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing somatic hypermutation and gene conversion in the chicken DT40 cell system.
    Kothapalli N; Fugmann SD
    Methods Mol Biol; 2011; 748():255-71. PubMed ID: 21701980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: a cis-acting DNA element targets AID-mediated sequence diversification to the chicken Ig light chain gene locus.
    Kothapalli N; Norton DD; Fugmann SD
    J Immunol; 2008 Feb; 180(4):2019-23. PubMed ID: 18250404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells.
    Ronai D; Iglesias-Ussel MD; Fan M; Shulman MJ; Scharff MD
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11829-34. PubMed ID: 16087866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl6 Is Required for Somatic Hypermutation and Gene Conversion in Chicken DT40 Cells.
    Williams AM; Maman Y; Alinikula J; Schatz DG
    PLoS One; 2016; 11(2):e0149146. PubMed ID: 26900682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion.
    Arakawa H; Hauschild J; Buerstedde JM
    Science; 2002 Feb; 295(5558):1301-6. PubMed ID: 11847344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID-mediated diversification within the IgL locus of chicken DT40 cells is restricted to the transcribed IgL gene.
    Gopal AR; Fugmann SD
    Mol Immunol; 2008 Apr; 45(7):2062-8. PubMed ID: 18023479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
    Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
    PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.
    Budzyńska PM; Kyläniemi MK; Kallonen T; Soikkeli AI; Nera KP; Lassila O; Alinikula J
    Eur J Immunol; 2017 Jun; 47(6):993-1001. PubMed ID: 28301039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation.
    Senigl F; Maman Y; Dinesh RK; Alinikula J; Seth RB; Pecnova L; Omer AD; Rao SSP; Weisz D; Buerstedde JM; Aiden EL; Casellas R; Hejnar J; Schatz DG
    Cell Rep; 2019 Dec; 29(12):3902-3915.e8. PubMed ID: 31851922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation.
    Chatterji M; Unniraman S; McBride KM; Schatz DG
    J Immunol; 2007 Oct; 179(8):5274-80. PubMed ID: 17911613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Targets Somatic Hypermutation to the Immunoglobulin Loci?
    Heltzel JMH; Gearhart PJ
    Viral Immunol; 2020 May; 33(4):277-281. PubMed ID: 31770070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of somatic hypermutation.
    Odegard VH; Schatz DG
    Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why does somatic hypermutation by AID require transcription of its target genes?
    Storb U
    Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cis-acting diversification activator both necessary and sufficient for AID-mediated hypermutation.
    Blagodatski A; Batrak V; Schmidl S; Schoetz U; Caldwell RB; Arakawa H; Buerstedde JM
    PLoS Genet; 2009 Jan; 5(1):e1000332. PubMed ID: 19132090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.
    Hengstschläger M; Williams M; Maizels N
    Eur J Immunol; 1994 Jul; 24(7):1649-56. PubMed ID: 8026525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the immunoglobulin locus specificity of hypermutation.
    Batrak V; Blagodatski A; Buerstedde JM
    Methods Mol Biol; 2011; 745():311-26. PubMed ID: 21660702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.